# Efficacy and Safety of Perindopril 5 mg / Indapamide 1.25 mg / Amlodipine 5 mg Fixed Combination in Hypertension

> **NCT05820880** · PHASE3 · COMPLETED · sponsor: **Institut de Recherches Internationales Servier** · enrollment: 532 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Fixed [Per/Ind/Aml]
- **DRUG:** Free [Per/Ind + Aml]

## Key facts

- **NCT ID:** NCT05820880
- **Lead sponsor:** Institut de Recherches Internationales Servier
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-06
- **Primary completion:** 2022-02-23
- **Final completion:** 2022-02-23
- **Target enrollment:** 532 (ACTUAL)
- **Last updated:** 2024-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05820880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05820880, "Efficacy and Safety of Perindopril 5 mg / Indapamide 1.25 mg / Amlodipine 5 mg Fixed Combination in Hypertension". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05820880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*